Medpace (MEDP) director granted 1,110 options at $415.27 per share

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Medpace Holdings, Inc. director Robert O. Kraft reported a new stock option award and his current share holdings. He received options to buy 1,110 shares of common stock at an exercise price of $415.27 per share, expiring on May 15, 2033. Following the award, he holds 922 shares of common stock directly. The option vests on the earlier of the day immediately before the first annual meeting after the grant date or the first anniversary of the grant date, subject to his continued service on the board.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Kraft Robert O.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	1,110	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 1,110 shares (Direct, null); Common Stock — 922 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Option shares granted: 1,110 shares Option exercise price: $415.27 per share Option expiration: May 15, 2033 +1 more

4 metrics

Option shares granted 1,110 shares Stock Option (Right to Buy) grant on May 15, 2026

Option exercise price $415.27 per share Exercise price for 1,110 stock options

Option expiration May 15, 2033 Expiration date of granted stock options

Common shares held 922 shares Direct holdings after reported transactions

Key Terms

Stock Option (Right to Buy), Grant, award, or other acquisition, exercise price, vesting

4 terms

Stock Option (Right to Buy) financial

"security_title": "Stock Option (Right to Buy)""

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

exercise price financial

"conversion_or_exercise_price": "415.2700""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Form 4 Insider Transactions: What Each Field Means →

05/18/2026 - 05:18 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kraft Robert O.

(Last)

(First)

(Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)

CINCINNATI

OHIO

45227

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								922	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$415.27	05/15/2026		A		1,110		⁽¹⁾	05/15/2033	Common Stock	1,110	$0	1,110	D

Explanation of Responses:

1. The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

Remarks:

	/s/ Stephen P. Ewald, Attorney-in-Fact for Robert O. Kraft	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Medpace (MEDP) director Robert O. Kraft report?

Robert O. Kraft reported receiving a new stock option grant. The award covers 1,110 shares of Medpace common stock and is structured as a compensation-related option, not an open-market share purchase or sale.

How many Medpace (MEDP) stock options were granted to Robert O. Kraft and at what price?

He was granted options for 1,110 shares of Medpace common stock. These options have an exercise price of $415.27 per share, meaning he can buy shares at that price when the options are exercised.

When do Robert O. Kraft’s new Medpace (MEDP) stock options vest?

The options vest on the earlier of two dates. Vesting occurs either the day immediately before the first annual shareholder meeting after the grant date, or on the first anniversary of the grant, if board service continues.

What is the expiration date of Robert O. Kraft’s Medpace (MEDP) stock options?

The granted stock options expire on May 15, 2033. After that date, any unexercised portion of the 1,110-share option award will lapse and can no longer be exercised at the $415.27 strike price.

How many Medpace (MEDP) common shares does Robert O. Kraft hold after this Form 4?

After the reported transactions, he holds 922 shares of Medpace common stock directly. This figure reflects his reported direct ownership and is separate from the 1,110 stock options awarded as compensation.

Is Robert O. Kraft’s Medpace (MEDP) Form 4 transaction an open-market buy or sell?

The filing shows a grant of stock options, not an open-market trade. The transaction is coded as a grant or award, indicating compensation rather than a discretionary purchase or sale of Medpace common stock.